Management and Advancements for Alzheimer’s Disease

Program Details

  • Intended Audience: Consultant pharmacists or pharmacists interested in Alzheimer’s Disease
  • Universal Activity Number: 0012-0000-19-037-H01-P
  • Contact Hours: 3.0 Consultant Recertification/General
  • Program Fees: $50.00
  • Dates Available: 12/10/2019 – 12/10/2021
  • Activity Type: Knowledge


This Alzheimer’s disease continuing education course covers pharmacologic and medical therapies, the role of pharmacists in caring for patients with Alzheimer’s, strategies for addressing the effects of the disease, and ways to support families and caregivers.

This program is approved by the Florida Board of Pharmacy for 3 consultant pharmacist recertification hours.


At the completion of this activity, the participant will be able to:

  • Describe the epidemiology and public impact of Alzheimer’s disease.
  • Summarize the pathophysiology of aging and Alzheimer’s disease.
  • Recognize risk factors for disease and measures for prevention.
  • Distinguish clinical manifestations of the disease versus normal aging.
  • Evaluate strategies for individualized patient care.
  • Describe pharmacologic and medical therapies available for Alzheimer’s disease.
  • Identify new and emerging developments in disease management.
  • Discuss factors regarding rehabilitation for patients with Alzheimer’s disease.
  • Provide support and resources for families and caregivers.
  • Describe legal and ethical considerations in the management of Alzheimer’s disease.

Disclosure Statement

The following speakers, reviewers, and planning committee members have disclosed that he/she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

  • Joseph S. Ladd, Pharm.D, BCPS (Author)
  • Randell Doty, Pharm.D (Content Reviewer)

Schedule of Activities and Requirements for Successful Course Completion

Review the course material, receive a 70% or higher on the post-test, and submit a course evaluation.

Credit Reporting

  • The University of Florida College of Pharmacy will report CPE credit to CPE Monitor and CE Broker when applicable. If you would like a paper statement of credit, you may print it from your NABP e-profile.
  • All pharmacists and pharmacy technicians maintain their own license and/or certification and it is their responsibility to follow up with the Office of Continuing Education at the University of Florida if any CE credit discrepancies are found.
  • It is at the University’s discretion to award or deny credit to a late claiming participant (i.e. after 60 days of the participant engaging in a CPE activity) as it is the University’s CE activity and the provider needs to ensure the requirements necessary for credit are successfully completed.
  • The University may request access to CPE Monitor® if the activity in question occurred within the previous 6 months and with an appropriate reason for access, i.e. power outage, etc.

Program Financial Support

This course received no financial program support.

Computer Requirements

Computer and Internet access are required to complete this course. Course content is provided via Canvas.

The minimum hardware, software, and Internet requirements for Canvas can be found here.


Refund Policy for CE Courses

Privacy and Confidentiality Policy


This course in its entirety is copyrighted by the University of Florida Continuing Pharmacy Education and may not be duplicated or reproduced for any other purpose without specific written permission.

Contact Us

For questions or more information, please contact our office.

ACPE logo

The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.